Trastuzumab emtansine: Antibody-drug conjugate in treatment of human epidermal growth factor receptor-2-positive metastatic breast cancer
The human epidermal growth factor receptor-2 (HER2)-targeted therapies have improved clinical outcomes for patients at any stage of HER2-positive breast cancer (BC). Trastuzumab, a monoclonal antibody that targets the HER2 receptor on BC cells, showed improved survival in metastatic BC (MBC). Howeve...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2018-01-01
|
| Серии: | Indian Journal of Medical and Paediatric Oncology |
| Предметы: | |
| Online-ссылка: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=1;spage=79;epage=87;aulast=Gogia |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|